An observational study in Refractive Errors and Astigmatism, sponsored by Taipei Nobel Eye Clinic. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2022-11-03.
Sponsored by Taipei Nobel Eye Clinic · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The aim of our study is to analysis and compare the relationship between ORA and postoperative astigmatism in low astigmatism (less than 1D) and moderate to high (1D to 3D) astigmatism patients after SMILE (Small Incision Lenticule Extraction) refractive surgery.
418 studies on the registry are indexed under Astigmatism; 51 are open to participants now.
This study's enrollment of 530 is above the median of 100 across 82 observational studies indexed under Astigmatism.
Browse Astigmatism studies →Taipei Nobel Eye Clinic is the lead sponsor of 5 studies on the registry; none are open to participants now.
Compared within Astigmatism, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Refractive Errors. The counts are of registry records indexed under each term, refreshed daily. How we classify →
This study was conducted by retrospective chart review in Taipei Nobel Eye Clinic from 2020 to 2022.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A 500 kHzVisumax (Carl Zeiss Meditec AG) femtosecond laser was used with cap thickness ranging from 100 to 130μm, cap diameter from 7.3 to 7.9 mm. The lenticule was dissected with a blunt spatula through a 30 to 60-degree incision at the 10 o'clock position and removed using forceps afterward. Treatment targets of both eyes were set to emmetropia, the refraction corrections were based on manifest refractions
Corrected distance visual acuity
in LogMAR unit
Time frame: 3 months after surgery
Manifest refraction
in Diopter
Time frame: 3 months after surgery
Plan to share: No
Ran from Jun 2020 to primary completion in Jun 2022, 24 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Taipei Nobel Eye Clinic